NCT02381444 Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy Status COMPLETED Phase N/A
NCT02365662 A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor Status TERMINATED Phase PHASE1
NCT02365649 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy Status COMPLETED Phase PHASE2
NCT02362074 Progress at Work - The Impact of Adalimumab on Work Related Productivity in Patients With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT02356562 A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection Status COMPLETED Phase PHASE2
NCT02349451 A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX) Status COMPLETED Phase PHASE2
NCT02343406 Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas Status COMPLETED Phase PHASE2
NCT02333383 Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients Status COMPLETED Phase N/A
NCT02322723 Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA Status WITHDRAWN Phase N/A
NCT02305758 Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02296905 Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic Function Status COMPLETED Phase PHASE1
NCT02292719 A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection Status COMPLETED Phase PHASE2
NCT02289729 Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease Status COMPLETED Phase N/A
NCT02289690 Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02287233 A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT02282982 Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis Status COMPLETED Phase N/A
NCT02272803 Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan Status COMPLETED Phase PHASE2
NCT02265731 Study Evaluating Venetoclax in Subjects With Hematological Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT02265237 A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1) Status COMPLETED Phase PHASE3